Literature DB >> 27757501

[Radiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models].

Moritz von Fallois1, Reinhard Depping2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27757501     DOI： 10.1007/s00066-016-1060-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Authors:  Claus Rödel; Ullrich Graeven; Rainer Fietkau; Werner Hohenberger; Torsten Hothorn; Dirk Arnold; Ralf-Dieter Hofheinz; Michael Ghadimi; Hendrik A Wolff; Marga Lang-Welzenbach; Hans-Rudolf Raab; Christian Wittekind; Philipp Ströbel; Ludger Staib; Martin Wilhelm; Gerhard G Grabenbauer; Hans Hoffmanns; Fritz Lindemann; Anke Schlenska-Lange; Gunnar Folprecht; Rolf Sauer; Torsten Liersch
Journal:  Lancet Oncol       Date:  2015-07-15       Impact factor: 41.316

2.  First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.

Authors:  Albiruni R Abdul Razak; Morten Mau-Soerensen; Nashat Y Gabrail; John F Gerecitano; Anthony F Shields; Thaddeus J Unger; Jean R Saint-Martin; Robert Carlson; Yosef Landesman; Dilara McCauley; Tami Rashal; Ulrik Lassen; Richard Kim; Lee-Anne Stayner; Mansoor R Mirza; Michael Kauffman; Sharon Shacham; Amit Mahipal
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

3.  Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development.

Authors:  Yong-Won Kwon; Il-Jin Kim; Di Wu; Jing Lu; William A Stock; Yueyong Liu; Yurong Huang; Hio Chung Kang; Reyno DelRosario; Kuang-Yu Jen; Jesus Perez-Losada; Guangwei Wei; Allan Balmain; Jian-Hua Mao
Journal:  Mol Cancer Res       Date:  2012-04-18       Impact factor: 5.852

Review 4.  The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.

Authors:  Gianni Capalbo; Claus Rödel; Roland H Stauber; Shirley K Knauer; Matthias Bache; Matthias Kappler; Franz Rödel
Journal:  Strahlenther Onkol       Date:  2007-11       Impact factor: 3.621

5.  XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer.

Authors:  Isabel Ferreiro-Neira; Nancy E Torres; Lukas F Liesenfeld; Carlos H F Chan; Tristan Penson; Yosef Landesman; William Senapedis; Sharon Shacham; Theodore S Hong; James C Cusack
Journal:  Clin Cancer Res       Date:  2015-11-24       Impact factor: 12.531

6.  Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.

Authors:  Jiankun Gao; Asfar S Azmi; Amro Aboukameel; Michael Kauffman; Sharon Shacham; Abdul-Badi Abou-Samra; Ramzi M Mohammad
Journal:  Oncotarget       Date:  2014-06-15
  6 in total
  1 in total

1.  Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.

Authors:  Rachel Sexton; Zaid Mahdi; Rahman Chaudhury; Rafic Beydoun; Amro Aboukameel; Husain Y Khan; Erkan Baloglu; William Senapedis; Yosef Landesman; Anteneh Tesfaye; Steve Kim; Philip A Philip; Asfar S Azmi
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.